Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Folate and cancer

This article was originally published in The Tan Sheet

Executive Summary

"Increased intake of folate from food sources, but not from supplements, may be associated with a reduced risk of pancreatic cancer," Susanna Larsson, National Institute of Environmental Medicine, Stockholm, Sweden, et al., conclude in the March 15 Journal of the National Cancer Institute. Authors prospectively followed 81,922 women and men who completed a 96-item food and supplement frequency questionnaire in 1997. Incidence of pancreatic cancer was ascertained through national and regional cancer registers. Each participant was followed from Jan. 1, 1998 through date of pancreatic cancer diagnosis, death from any cause, migration or Dec. 31, 2004, whichever occurred first. Although dietary folate was inversely associated with pancreatic cancer, "there was no association between folic acid from supplements and pancreatic cancer risk." The reasons for the different effects are "unclear," according to the authors. However "one possibility is that folate from food sources better represents long-term folate intake than folic acid from (recent and possibly irregular) use of supplements, and long-term regular exposure to folate may be more relevant to carcinogenesis"...
Advertisement

Related Content

Food-Based Folate, B Vitamins May Lower Pancreatic Cancer Risk – AACR

Topics

Advertisement
UsernamePublicRestriction

Register

PS099216

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel